Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancer
Authors:
- Anurag SharmaASAnurag Sharma
- Sai V. VemulaSVSai V. Vemula
- Dinesh S. BangariDBDinesh S. Bangari
- Suresh K. MittalSuresh K. Mittal
- 1 January 2012
- journal article
- Published by Elsevier in Virus Research
- Vol. 163 (1) , 202-211
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (CA110176)
This publication has 32 references indexed in Scilit:
- Evaluation of innate immunity and vector toxicity following inoculation of bovine, porcine or human adenoviral vectors in a mouse modelVirus Research, 2010
- Influence of chimeric human-bovine fibers on adenoviral uptake by liver cells and the antiviral immune responseGene Therapy, 2010
- Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenovirusesGene Therapy, 2010
- Bovine adenovirus serotype 3 utilizes sialic acid as a cellular receptor for virus entryVirology, 2009
- Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse modelVirology, 2009
- Bovine Adenoviral Vector–based H5N1 Influenza Vaccine Overcomes Exceptionally High Levels of Pre-existing Immunity Against Human AdenovirusMolecular Therapy, 2008
- Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in cultureBiochemical and Biophysical Research Communications, 2005
- Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapyCancer Gene Therapy, 2004
- The fibre of bovine adenovirus type 3 is very long but bentJournal of General Virology, 1994
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977